Skip to main content

Articles

Page 9 of 70

  1. Radiotherapy (RT) is part of the curative treatment of approximately 70% of breast cancer (BC) patients. Wide practice variation has been reported in RT dose, fractionation and its treatment planning for BC. T...

    Authors: Nansi Maliko, Marcel R. Stam, Liesbeth J. Boersma, Marie-Jeanne T. F. D. Vrancken Peeters, Michel W. J. M. Wouters, Eline KleinJan, Maurice Mulder, Marion Essers, Coen W. Hurkmans and Nina Bijker
    Citation: Radiation Oncology 2022 17:73
  2. Hypersensitivity towards proton versus photon irradiation was demonstrated in homologous recombination repair (HRR)-deficient cell lines. Hence, combined treatment concepts targeting HRR provide a rational for...

    Authors: Simon Deycmar, Elisabeth Mara, Sylvia Kerschbaum-Gruber, Verena Waller, Dietmar Georg and Martin Pruschy
    Citation: Radiation Oncology 2022 17:72
  3. We compared the oncological outcomes of patients who received seed brachytherapy (SEED-BT) with those who received radical prostatectomy (RP) for intermediate-risk prostate cancer.

    Authors: Hideyasu Tsumura, Nobumichi Tanaka, Tomohiko Oguchi, Takuya Owari, Yasushi Nakai, Isao Asakawa, Kazuyoshi Iijima, Haruaki Kato, Iwao Hashida, Ken-ichi Tabata, Takefumi Satoh and Hiromichi Ishiyama
    Citation: Radiation Oncology 2022 17:71
  4. To quantify the pelvic bone marrow (PBM) fat content changes receiving different radiation doses of concurrent chemoradiotherapy for cervical cancer and to determine association with peripheral blood cell counts.

    Authors: Cong Wang, Xiaohang Qin, Guanzhong Gong, Lizhen Wang, Ya Su and Yong Yin
    Citation: Radiation Oncology 2022 17:70
  5. Four-dimensional cone-beam computed tomography (4D-CBCT) can visualize moving tumors, thus adaptive radiation therapy (ART) could be improved if 4D-CBCT were used. However, 4D-CBCT images suffer from severe im...

    Authors: Keisuke Usui, Koichi Ogawa, Masami Goto, Yasuaki Sakano, Shinsuke Kyougoku and Hiroyuki Daida
    Citation: Radiation Oncology 2022 17:69
  6. Curative treatment of inoperable post-irradiation sarcoma is often challenging, especially using radiotherapy, wherein curative dose administration is difficult because the organs around the tumor have already...

    Authors: Shintaro Shiba, Masahiko Okamoto, Takashi Yanagawa, Isaku Kohama, Kei Shibuya, Shohei Okazaki, Yuhei Miyasaka, Hirotaka Chikuda and Tatsuya Ohno
    Citation: Radiation Oncology 2022 17:68
  7. To report results from our phase II study of stereotactic body radiotherapy (SBRT) delivering 36 Gy in 4 fractions for patients with localized prostate cancer.

    Authors: S. Kawakami, H. Tsumura, T. Satoh, K. Tabata, A. Sekiguchi, T. Kainuma, M. Nakano, M. Iwamura and H. Ishiyama
    Citation: Radiation Oncology 2022 17:67
  8. The use of treatment planning prostate MRI for Stereotactic Body Radiation Therapy (SBRT) is largely a standard, yet not all patients can receive MRI for a variety of clinical reasons. Thus, we aim to investig...

    Authors: Katherine Amarell, Anna Jaysing, Christopher Mendez, Jonathan A. Haas, Seth R. Blacksburg, Aaron E. Katz, Astrid Sanchez, Angela Tong, Todd Carpenter, Matthew Witten, Sean P. Collins and Jonathan W. Lischalk
    Citation: Radiation Oncology 2022 17:66
  9. Automatic prostate tumor segmentation is often unable to identify the lesion even if multi-parametric MRI data is used as input, and the segmentation output is difficult to verify due to the lack of clinically...

    Authors: Deepa Darshini Gunashekar, Lars Bielak, Leonard Hägele, Benedict Oerther, Matthias Benndorf, Anca-L. Grosu, Thomas Brox, Constantinos Zamboglou and Michael Bock
    Citation: Radiation Oncology 2022 17:65
  10. To examine the dosimetric feasibility of hypofractionated/dose escalated radiation therapy in patients with localized prostate carcinoma using simultaneous integrated boost intensity-modulated proton beam ther...

    Authors: Dalia Ahmad Khalil, Danny Jazmati, Dirk Geismar, Jörg Wulff, Christian Bäumer, Paul Heinz Kramer, Theresa Steinmeier, Stefanie Schulze Schleitthoff, Sandija Plaude, Martin Bischoff, Stephan Tschirdewahn, Boris Hadaschik and Beate Timmermann
    Citation: Radiation Oncology 2022 17:64
  11. Radiotherapy is an effective regimen for cancer treatment alone or combined with chemotherapy or immunotherapy. The direct effect of radiotherapy involves radiation-induced DNA damage, and most studies have fo...

    Authors: Lei Wang, Jizong Jiang, Yuan Chen, Qingzhu Jia and Qian Chu
    Citation: Radiation Oncology 2022 17:63
  12. Prostate alignment is subject to interobserver variability in cone-beam CT (CBCT)-based soft-tissue matching. This study aims to analyze the impact of possible interobserver variability in CBCT-based soft-tiss...

    Authors: Xiangbin Zhang, Xin Wang, Xiaoyu Li, Li Zhou, Shihong Nie, Changhu Li, Xuetao Wang, Guyu Dai, Zhonghua Deng and Renming Zhong
    Citation: Radiation Oncology 2022 17:62
  13. There is currently no standard treatment for locoregional recurrence of esophageal squamous cell carcinoma (ESCC) previously treated with radiotherapy. This study aimed to assess the efficacy and safety of re-...

    Authors: Kuntian Lan and Jiaohong Chen
    Citation: Radiation Oncology 2022 17:61
  14. This study aimed at evaluating the clinical impact of full intensity-modulated radiotherapy (IMRT), hybrid IMRT (H-IMRT) and hybrid volumetric-modulated arc therapy (H-VMAT) for early-stage breast cancer with ...

    Authors: Suyan Bi, Rui Zhu and Zhitao Dai
    Citation: Radiation Oncology 2022 17:60
  15. Stereotactic body radiotherapy (SBRT) is an established local treatment method for patients with hepatic oligometastasis or oligoprogression. Liver metastases often occur in close proximity to radiosensitive o...

    Authors: P. Hoegen, K. S. Zhang, E. Tonndorf-Martini, F. Weykamp, S. Regnery, P. Naumann, K. Lang, J. Ristau, S. A. Körber, C. Dreher, C. Buchele, C. Rippke, C. K. Renkamp, K. M. Paul, L. König, C. Büsch…
    Citation: Radiation Oncology 2022 17:59
  16. The low incidence of primary mediastinal seminomas has precluded the development of clinical trials on mediastinal seminomas. We investigated the clinicopathologic characteristics, prognosis of patients with p...

    Authors: Yirui Zhai, Bo Chen, Xiaoli Feng, Kan Liu, Shulian Wang, Zhouguang Hui, Qinfu Feng, Junling Li, Zefen Xiao, Jima Lv, Yushun Gao, Yueping Liu, Hui Fang, Jianyang Wang, Lei Deng, Wenyang Liu…
    Citation: Radiation Oncology 2022 17:58
  17. The aim of the study is to identify clinical and dosimetric factors that could predict the risk of hypothyroidism in nasopharyngeal carcinoma (NPC) patients following intensity-modulated radiotherapy (IMRT).

    Authors: Ruiping Zhai, Yingchen Lyu, Mengshan Ni, Fangfang Kong, Chengrun Du, Chaosu Hu and Hongmei Ying
    Citation: Radiation Oncology 2022 17:57
  18. Interstitial pneumonia (IP) is a disease with a poor prognosis. In addition, IP patients are more likely to develop lung cancer. Since IP patients frequently develop toxicities during cancer treatment, minimal...

    Authors: Shingo Hashimoto, Hiromitsu Iwata, Yukiko Hattori, Koichiro Nakajima, Kento Nomura, Kensuke Hayashi, Toshiyuki Toshito, Eiko Yamamori, Kenji Akita, Jun-etsu Mizoe, Hiroyuki Ogino and Yuta Shibamoto
    Citation: Radiation Oncology 2022 17:56
  19. Previous work on Magnetic Resonance Imaging (MRI) only planning has been applied to limited treatment regions with a focus on male anatomy. This research aimed to validate the use of a hybrid multi-atlas synth...

    Authors: Laura M. O’Connor, Jason A. Dowling, Jae Hyuk Choi, Jarad Martin, Helen Warren-Forward, Haylea Richardson, Leah Best, Kate Skehan, Mahesh Kumar, Geetha Govindarajulu, Swetha Sridharan and Peter B. Greer
    Citation: Radiation Oncology 2022 17:55
  20. Prostate cancer (PCa) is known to be suitable for hypofractionated radiotherapy due to the very low α/β ratio (about 1.5–3 Gy). However, several randomized controlled trials have not shown the superiority of h...

    Authors: Ming Cui, Xian-Shu Gao, Xiaoying Li, Mingwei Ma, Xin Qi and Yuta Shibamoto
    Citation: Radiation Oncology 2022 17:54
  21. Hybrid magnetic resonance (MR)-Linac systems have recently been introduced into clinical practice. The systems allow online adaption of the treatment plan with the aim of compensating for interfractional anato...

    Authors: Lukas Nierer, Chukwuka Eze, Vanessa da Silva Mendes, Juliane Braun, Patrick Thum, Rieke von Bestenbostel, Christopher Kurz, Guillaume Landry, Michael Reiner, Maximilian Niyazi, Claus Belka and Stefanie Corradini
    Citation: Radiation Oncology 2022 17:53
  22. To summarize the characteristics of local invasion and distribution of metastatic lymph nodes in unilateral nasopharyngeal carcinoma (NPC) by magnetic resonance imaging (MRI) to provide references for the opti...

    Authors: Zheng Wu, Lin Zhang, Qian He, Feiping Li, Hongzhi Ma, Yujuan Zhou, Hui Wang and Yaqian Han
    Citation: Radiation Oncology 2022 17:52
  23. Upper tract urothelial carcinoma (UTUC) is rare and the treatment for recurrent or metastatic UTUC is unclear. We evaluated the outcomes of salvage and palliative radiotherapy (RT) and prognostic factors in UT...

    Authors: Mi Sun Kim, Woong Sub Koom, Jae Ho Cho, Se-Young Kim and Ik Jae Lee
    Citation: Radiation Oncology 2022 17:51
  24. Variable relative biological effectiveness (vRBE) in proton therapy might significantly modify the prediction of RBE-weighted dose delivered to a patient during proton therapy. In this study we will present a ...

    Authors: Magdalena Garbacz, Jan Gajewski, Marco Durante, Kamil Kisielewicz, Nils Krah, Renata Kopeć, Paweł Olko, Vincenzo Patera, Ilaria Rinaldi, Marzena Rydygier, Angelo Schiavi, Emanuele Scifoni, Tomasz Skóra, Agata Skrzypek, Francesco Tommasino and Antoni Rucinski
    Citation: Radiation Oncology 2022 17:50
  25. In-field dermatitis is a severe and common adverse effect of radiation therapy, that can cause significant pain and treatment interruptions in patients with squamous cell anal carcinoma (SCAC) being treated wi...

    Authors: Fabiana Hottz, Daniel Herchenhorn, Juliana Lenzi, Juliana Andrade, Vinicius Freire and Pedro Pinho
    Citation: Radiation Oncology 2022 17:49
  26. To explore clinical and dosimetric predictors of acute hematologic toxicity (HT) in cervical cancer patients treated with concurrent chemotherapy and volumetric-modulated arc therapy (VMAT).

    Authors: Xiaoyong Xiang, Zhen Ding, Qi Zeng, Lingling Feng, Chunyan Qiu, Dongjie Chen, Jiawei Lu and Ning Li
    Citation: Radiation Oncology 2022 17:48
  27. To study lymphatic recurrence distribution after radical surgery in the real world and guide clinical tumor volume delineation for regional lymph nodes during postoperative radiotherapy for lower thoracic squa...

    Authors: Rongxu Du, Songqing Fan, Xiaobin Wang, Xia Hou, Cheng Zeng, Dan Guo, Rongrong Tian, Dan Yang, Leilei Jiang, Xin Dong, Rong Yu, Huiming Yu, Dongming Li, Shuchai Zhu, Jie Li and Anhui Shi
    Citation: Radiation Oncology 2022 17:47
  28. The interplay effect of respiratory motion on the planned dose in free-breathing right-sided whole-breast irradiation (WBI) were studied by simulating hypofractionated VMAT treatment courses.

    Authors: Mikko Mankinen, Tuomas Virén, Jan Seppälä, Heikki Hakkarainen and Tuomas Koivumäki
    Citation: Radiation Oncology 2022 17:46
  29. Multimodal therapies based on surgical resection have been recommended for the treatment of adenocarcinoma of the oesophagogastric junction (AEG). We aimed to evaluate prognostic factors in AEG patients receiv...

    Authors: Rongxu Du, Jiao Ming, Jianhao Geng, Xianggao Zhu, Yangzi Zhang, Shuai Li, Zhiyan Liu, Hongzhi Wang, Zhilong Wang, Lei Tang, Xiaotian Zhang, Aiwen Wu, Zhaode Bu, Yan Yan, Zhongwu Li, Yongheng Li…
    Citation: Radiation Oncology 2022 17:45
  30. Online MR-guided radiotherapy (MRgRT) is a relatively novel advancement in the field of radiation oncology, ensuring superior soft-tissue visualisation, allowing for online plan adaptation to anatomical and fu...

    Authors: Chukwuka Eze, Elia Lombardo, Lukas Nierer, Yuqing Xiong, Maximilian Niyazi, Claus Belka, Farkhad Manapov and Stefanie Corradini
    Citation: Radiation Oncology 2022 17:43
  31. In infrared reflective (IR) marker-based hybrid real-time tumor tracking (RTTT), the internal target position is predicted with the positions of IR markers attached on the patient’s body surface using a predic...

    Authors: Dejun Zhou, Mitsuhiro Nakamura, Nobutaka Mukumoto, Hiroaki Tanabe, Yusuke Iizuka, Michio Yoshimura, Masaki Kokubo, Yukinori Matsuo and Takashi Mizowaki
    Citation: Radiation Oncology 2022 17:42
  32. The aim of this study was to clarify the association between intrafractional prostate shift and hydrogel spacer.

    Authors: Subaru Sawayanagi, Hideomi Yamashita, Mami Ogita, Ryosuke Takenaka, Yuki Nozawa, Yuichi Watanabe, Toshikazu Imae and Osamu Abe
    Citation: Radiation Oncology 2022 17:41
  33. Some patients have noted a foul odor during radiation therapy sessions, but the cause of the odor remains unknown. Since we suspected that this phenomenon is due to ozone generated by ionizing radiation, this ...

    Authors: N. Hara, J. Oobuchi, A. Isobe, S. Sugimoto, J. Takatsu and K. Sasai
    Citation: Radiation Oncology 2022 17:39
  34. Boosting dominant intra-prostatic lesions (DILs) has the potential to increase the therapeutic ratio in prostate cancer radiotherapy. In this study, employing 5-fraction stereotactic ablative radiotherapy (SAB...

    Authors: Sarah O. S. Osman, Ciaran Fairmichael, Glenn Whitten, Gavin S. Lundy, Rachel Wesselman, Melissa LaBonte Wilson, Alan R. Hounsell, Kevin M. Prise, Denise Irvine, Conor K. McGarry and Suneil Jain
    Citation: Radiation Oncology 2022 17:38
  35. The use of stereotactic body radiation therapy (SBRT) for tumor and pain control in patients with bone metastases is increasing. We report response assessment after bone SBRT using radiological changes through...

    Authors: Dora Correia, Barbara Moullet, Jennifer Cullmann, Rafael Heiss, Ekin ErmiÅŸ, Daniel M. Aebersold and Hossein Hemmatazad
    Citation: Radiation Oncology 2022 17:37
  36. The impact of radiotherapy interruption due to the Spring Festival holidays in China on the survival of patients with nasopharyngeal carcinoma (NPC) is unclear.

    Authors: Cheng Xu, Kai-Bin Yang, Rui-Jia Feng, Lei Chen, Xiao-Jing Du, Yan-Ping Mao, Wen-Fei Li, Qing Liu, Ying Sun and Jun Ma
    Citation: Radiation Oncology 2022 17:36
  37. This study aimed to investigate preoperative spirometry and BMI as early predictors of the mean heart and lung dose (MHD, MLD) in deep inspiration breath-hold (DIBH) radiotherapy.

    Authors: Yutaro Koide, Hidetoshi Shimizu, Takahiro Aoyama, Tomoki Kitagawa, Risei Miyauchi, Yui Watanabe, Hiroyuki Tachibana and Takeshi Kodaira
    Citation: Radiation Oncology 2022 17:35
  38. Vaginal bleeding (VB) is common in women with gynecologic (GYN) malignancies. Radiation therapy (RT) is used for the definitive treatment of GYN cancers and palliation of bleeding. The historical dogma is that...

    Authors: Luke A. Moradi, Craig S. Schneider, Alok S. Deshane, Richard A. Popple, Robert Y. Kim and Samuel R. Marcrom
    Citation: Radiation Oncology 2022 17:34
  39. To date, no data on the effect of adjuvant postmastectomy radiotherapy (PMRT) on oncologic outcomes, such as all-cause death, locoregional recurrence (LRR), and distant metastasis (DM), are available in women ...

    Authors: Jiaqiang Zhang, Shao-Yin Sum, Jeng-Guan Hsu, Ming-Feng Chiang, Tian-Shyug Lee and Szu-Yuan Wu
    Citation: Radiation Oncology 2022 17:33
  40. Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy (GPT) for non-metastatic, locally advanced pancreatic cancer (LAPC) remain unclear. This study aimed to determine the fa...

    Authors: Yuta Ogura, Kazuki Terashima, Yoshihide Nanno, SungChul Park, Masaki Suga, Daiki Takahashi, Yoshiro Matsuo, Nor Shazrina Sulaiman, Sunao Tokumaru, Tomoaki Okimoto, Hirochika Toyama and Takumi Fukumoto
    Citation: Radiation Oncology 2022 17:32
  41. This paper describes the development of a predicted electronic portal imaging device (EPID) transmission image (TI) using Monte Carlo (MC) and deep learning (DL). The measured and predicted TI were compared fo...

    Authors: Jun Zhang, Zhibiao Cheng, Ziting Fan, Qilin Zhang, Xile Zhang, Ruijie Yang and Junhai Wen
    Citation: Radiation Oncology 2022 17:31
  42. Several studies have reported patient-related risk factors for late rectal bleeding following conventionally fractionated radiotherapy for prostate cancer. We investigated patient-related risk factors for late...

    Authors: Tae Gyu Kim, Byungdo Park, Yun Gyu Song, Hyoun Wook Lee, Tae Hee Oh, Dong-Soo Ryu, Seung Chan Jeong, Daehyeon Cho, Jieun Oh, Kwang Min Kim, Jung Won Lee, Hyoun Soo Lee, Sung Min Kong, Jun Young Kim and Haeyoung Kim
    Citation: Radiation Oncology 2022 17:30
  43. Stage III non-small cell lung cancer (NSCLC) represents a highly heterogeneous disease and treatment burden. Advances in imaging modality show promising results for radiotherapy planning. In this multicentric ...

    Authors: Matthias Mäurer, Lukas Käsmann, Daniel F. Fleischmann, Michael Oertel, Danny Jazmati and Daniel Medenwald
    Citation: Radiation Oncology 2022 17:29
  44. With the rapid growth of deep learning research for medical applications comes the need for clinical personnel to be comfortable and familiar with these techniques. Taking a proven approach, we developed a str...

    Authors: John C. Asbach, Anurag K. Singh, L. Shawn Matott and Anh H. Le
    Citation: Radiation Oncology 2022 17:28
  45. Current literature lacks a comparison of lymph node metastases and non-pathological lymph nodes distribution in breast cancer patients. The aim of the current retrospective study was to generate a comprehensiv...

    Authors: Kai J. Borm, Lucia Ernst, Julia Voppichler, Markus Oechsner, Mathias Düsberg, Gabriel Buschner, Wolfgang Weber, Stephanie E. Combs and Marciana N. Duma
    Citation: Radiation Oncology 2022 17:27
  46. In the modern era of magnetic resonance imaging (MRI) staging, the benefit of prophylactic cranial irradiation (PCI) in patients with small-cell lung cancer (SCLC) has been controversial. This study evaluated ...

    Authors: Yu Jin Lim, Changhoon Song and Hak Jae Kim
    Citation: Radiation Oncology 2022 17:26
  47. Artificial intelligence (AI) shows great potential to streamline the treatment planning process. However, its clinical adoption is slow due to the limited number of clinical evaluation studies and because ofte...

    Authors: Esther Kneepkens, Nienke Bakx, Maurice van der Sangen, Jacqueline Theuws, Peter-Paul van der Toorn, Dorien Rijkaart, Jorien van der Leer, Thérèse van Nunen, Els Hagelaar, Hanneke Bluemink and Coen Hurkmans
    Citation: Radiation Oncology 2022 17:25

Annual Journal Metrics

  • 2022 Citation Impact
    3.6 - 2-year Impact Factor
    3.8 - 5-year Impact Factor
    1.370 - SNIP (Source Normalized Impact per Paper)
    1.037 - SJR (SCImago Journal Rank)

    2023 Speed
    16 days submission to first editorial decision for all manuscripts (Median)
    132 days submission to accept (Median)

    2023 Usage 
    1,958,690 downloads
    605 Altmetric mentions